Prognostic implications of human leukocyte antigen class i expression in patients who underwent surgical resection for non-small-cell lung cancer

Journal of Surgical Research

Volumn 181, Issue 2, 2013, Pages

  Hanagiri, Takeshi ^a   Shigematsu, Yoshiki ^a   Kuroda, Koji ^a   Baba, Tetsuro ^a   Shiota, Hironobu ^a   Ichiki, Yoshinobu ^a   Nagata, Yoshika ^a   Yasuda, Manabu ^a   Uramoto, Hidetaka ^a   So, Tomoko ^a   Takenoyama, Mitsuhiro ^a   Tanaka, Fumihiro ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

HLA class I expression; Immune escape; Immunohistochemical staining; Non small cell lung cancer; Prognosis; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; HLA ANTIGEN CLASS 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84876414840     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.07.029     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277
2. S.H. Ou, and J.A. Zell Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry J Thorac Oncol 3 2008 216
3. H. Asamura, T. Goya, Y. Koshiishi Japanese Joint Committee of Lung Cancer Registry A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers J Thorac Oncol 3 2008 46
4. P. Goldstraw, J. Crowley, K. Chansky International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706
5. S.G. Spiro, and G.A. Silvestri One hundred years of lung cancer Am J Respir Crit Care Med 172 2005 523
6. F. Mami-Chouaib, H. Echchakir, G. Dorothée, I. Vergnon, and S. Chouaib Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen Immunol Rev 188 2002 114
7. L. Moretta, C. Bottino, D. Pende, M.C. Mingari, R. Biassoni, and A. Moretta Human natural killer cells: their origin, receptors and function Eur J Immunol 32 2002 1205
8. T. Baba, T. Hanagiri, and Y. Ichiki Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B Cancer Sci 98 2007 1795
9. G.P. Dunn, A.T. Bruce, H. Ikeda, L.J. Old, and R.D. Schreiber Cancer immunoediting: from immunosurveillance to tumor escape Nat Immunol 3 2002 991
10. W.D. Travis, T.V. Colby, B. Corrin, Y. Shimosato, and E. Brambilla Histological type of lung and pleural tumors. World Health Organization international histological classification of tumors 3rd ed. 1999 Springer Berlin
11. H. Shimokawa, H. Uramoto, and T. Onitsuka TS expression predicts postoperative recurrence in adenocarcinoma of the lung Lung Cancer 72 2011 360
12. J.M.H.C. Bubeník class I down-regulation: tumour escape from immune surveillance? Int J Oncol 25 2004 487
13. T. So, M. Takenoyama, and M. Mizukami Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer Cancer Res 65 2005 5945
14. F. Garrido, T. Cabrera, A. Concha, S. Glew, F. Ruiz-Cabello, and P.L. Stern Natural history of HLA expression during tumour development Immunol Today 14 1993 491
15. M.J. Smyth, G.P. Dunn, and R.D. Schreiber Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity Adv Immunol 90 2006 1
16. B. Seliger Molecular mechanisms of MHC class I abnormalities and APM components in human tumors Cancer Immunol Immunother 57 2008 1719
17. T. Cabrera, I. Maleno, A. Collado, M.A. Lopez Nevot, B.D. Tait, and F. Garrido Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms Tissue Antigens 69 Suppl. 1 2007 264
18. M. Redondo, A. Concha, and F. Ruiz-Cabello Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas Cancer Detect Prev 21 1997 22
19. T. Kageshita, S. Hirai, T. Ono, D.J. Hicklin, and S. Ferrone Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression Am J Pathol 154 1999 745
20. N. Bandoh, T. Ogino, and A. Katayama HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis Oncol Rep 23 2010 933
21. E.M. de Kruijf, J.G. van Nes, and A. Sajet The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer Clin Cancer Res 16 2010 1272
22. B. Passlick, J.R. Izbicki, and S. Simmel Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: frequency and prognostic significance Eur J Cancer 30A 1994 376
23. N. Ramnath, D. Tan, and Q. Li Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival? Cancer Immunol Immunother 27 2005 1
24. E. Kikuchi, K. Yamazaki, and T. Torigoe HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer Cancer Sci 98 2007 1424
25. K. Kaneko, S. Ishigami, and Y. Kijima Clinical implication of HLA class I expression in breast cancer BMC Cancer 11 2011 454
26. Z. Madjd, I. Spendlove, S.E. Pinder, I.O. Ellis, and L.G. Durrant Total loss of MHC class I is an independent indicator of good prognosis in breast cancer Int J Cancer 117 2005 248
27. H.W. Lee, S.K. Min, and Y.S. Ju Prognostic significance of HLA class I expressing in gastric carcinoma defined by monoclonal anti-pan HLA class I antibody, EMR8-5 J Gastrointest Surg 15 2011 1336
28. T. Ogino, H. Shigyo, and H. Ishii HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker Cancer Res 66 2006 9281
29. N.F. Watson, J.M. Ramage, and Z. Madjd Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis Int J Cancer 118 2006 6
30. E. Kikuchi, K. Yamazaki, and E. Nakayama Prolonged survival of patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigens Cancer Immunol 8 2008 13